TY  - GEN
AU  - Leonardi,Giulia C
AU  - Oxnard,Geoffrey R
AU  - Haas,Andrea
AU  - Lang,Joshua P
AU  - Williams,Jonathan S
AU  - Awad,Mark M
TI  - Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non-Small Cell Lung Cancer
SN  - 1537-4513
PY  - 2018///0319
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Antineoplastic Agents
KW  - Autoantibodies
KW  - blood
KW  - Carcinoma, Non-Small-Cell Lung
KW  - complications
KW  - Diabetic Ketoacidosis
KW  - diagnosis
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Glutamate Decarboxylase
KW  - immunology
KW  - Humans
KW  - Immunotherapy
KW  - Insulin
KW  - therapeutic use
KW  - Lung Neoplasms
KW  - Male
KW  - Programmed Cell Death 1 Receptor
KW  - Remission Induction
N1  - Publication Type: Case Reports; Journal Article
UR  - https://doi.org/10.1097/CJI.0000000000000173
ER  -